Rumored Buzz on Telaglenastat

The first aim of the study was to look at the position of glutaminase inhibition as a method to address adaptive resistance to IR in head and neck cancer. The combination of glutaminase inhibition with telaglenastat and IR was compared to the consequences of independent treatment on your own in clon

read more